These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9036657)

  • 21. [The effect of peroral administration of the mucolytic Mucopront on the ultrastructure of the epithelium of the respiratory tract].
    Konrádová V; Vávrová V; Sůlová J
    Cesk Pediatr; 1982 Sep; 37(9):497-500. PubMed ID: 7139784
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of some clinical-pharmacological studies on ambroxol (NA 872)].
    Renovanz VK
    Arzneimittelforschung; 1975 Apr; 25(4):646-52. PubMed ID: 1174081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carbocysteine-sobrerol combination and exacerbation of chronic bronchitis].
    Pasturenzi L; Donnetta AM; Gualtieri G; Luisetti M
    Arch Monaldi Mal Torace; 1988; 43(6):487-505. PubMed ID: 3155012
    [No Abstract]   [Full Text] [Related]  

  • 24. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis.
    Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE
    Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
    Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
    Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the timing of inhaled dornase alfa matter?
    van der Giessen L
    J Cyst Fibros; 2009 Jun; 8 Suppl 1():S6-9. PubMed ID: 19460684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative mucolytic drug therapy].
    App EM
    Pneumologie; 1996 Dec; 50 Suppl 3():845-53. PubMed ID: 9157441
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mucolytic drugs: towards a contraindication in infants].
    Mourdi N; Dubus JC; Bavoux F; Boyer-Gervoise M; Jean-Pastor MJ; Chalumeau M
    Arch Pediatr; 2010 Jun; 17(6):735-6. PubMed ID: 20654866
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchial drainage prior to bronchography--a possible modification.
    Nigam BK
    Thorac Cardiovasc Surg; 1983 Feb; 31(1):49. PubMed ID: 6189253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effect of three oral mucolytics on the ultrastructure of the tracheal epithelium in rabbits.
    Konrádová V; Vávrová V; Sulová J
    Respiration; 1985; 48(1):50-7. PubMed ID: 3927460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy and safety of ciprofloxacin in treating children with mucoviscidosis].
    Postnikov SS; Semykin SIu; Kapranov NI; Perederko LV; Polikarpova SV
    Antibiot Khimioter; 2000; 45(4):14-7. PubMed ID: 10851644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bronchial secretion and blood levels of gentamicin, in gentamicin treated children with mucoviscidosis].
    Vogt E
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):444-7. PubMed ID: 4572076
    [No Abstract]   [Full Text] [Related]  

  • 34. [Statistical findings on flora isolated from sputum of mucoviscidosis patients].
    Mengoli V; Bonomi U; Mastella G; Piacentini I; Barbato GP; Girelli-Bruni E; Bellini P
    Fracastoro; 1970; 63(3):549-61. PubMed ID: 5517028
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
    Fadda G
    Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled antimicrobial therapy.
    O'Riordan T; Faris M
    Respir Care Clin N Am; 1999 Dec; 5(4):617-31. PubMed ID: 10565884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The mucolytic therapy of chronic obstructive bronchitis].
    Shchennikov EL
    Klin Med (Mosk); 1995; 73(1):44-6. PubMed ID: 7791306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regeneration of changes induced in rabbit tracheal epithelium by a single oral dose of a mucolytic agent.
    Konrádová V; Vávrová V; Sulová J
    Folia Morphol (Praha); 1986; 34(1):52-8. PubMed ID: 3699638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.